Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells

@article{FidanYaylal2015AntidiabeticEA,
  title={Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells},
  author={G{\"u}zin Fidan-Yaylalı and Yavuz Dodurga and M{\"u}cahit Seçme and Levent Elmas},
  journal={Tumor Biology},
  year={2015},
  volume={37},
  pages={2647-2653}
}
Exendin-4 is a GLP-1 analog used for the treatment of type 2 diabetes mellitus in its synthetic form. As women with diabetes have higher breast cancer incidence and mortality, we examined the effect of the incretin drug exendin-4 on breast cancer cells. The aim of the study is to investigate anticancer mechanism of exendin-4 in MCF-7 breast cancer cells… CONTINUE READING